RO60 and Castleman-Kojima disease: Additionally, a recent report from Japan suggested that anti-SS-A/Ro60 antibodies may be involved in the disease characteristics of TAFRO syndrome, which may contribute to understanding the disease and selecting treatment methods in the future [19].